Screening/assessment for conditions relevant to GLP‐1 useGastrointestinal symptoms or disordersAffective disorders/mood disorders, suicidal thoughtsBinge eating disorder, anorexia nervosa, bulimia nervosa, and night eating disorderaSarcopenia, osteopeniaNephrolithiasis or renal impairment. The gene discussed is GCG; the disease is bulimia nervosa.